Browse everything: Tickers A–Z · Issuers · Comparisons · Tags
LAB Stock — Standard Biotools Inc
Standard Biotools Inc (LAB)
Updated October 16, 2026.
LAB is a Stock. Total return is -95.5% over the past 15.7 years, 755.4 points behind SPY at 659.9%.
Standard BioTools Inc. develops and sells instrumentation, consumables, and services for proteomics and genomics research, serving academic institutions, biotech companies, and clinical laboratories through platforms including SomaScan for protein analysis, CyTOF for cell analysis, Hyperion for spatial biology, and Biomark X9 for genomics applications. The company does not currently distribute to shareholders. This equity is suited for growth-oriented investors seeking exposure to life sciences research tools without reliance on dividend income.
LAB performance versus SPY
Price and return data through 2026-10-16.
Total return is -95.5% over the past 15.7 years, 755.4 points behind SPY at 659.9%. Over the past year its total return — price change plus distributions reinvested — is -51.2%. Its deepest 1-year drawdown was 62.6%.
| Window | Total return | CAGR |
|---|---|---|
| 1M | -11.4% | — |
| 3M | -26.9% | — |
| 6M | -31.6% | — |
| YTD | -50.9% | — |
| 1Y | -51.2% | — |
| 2Y CAGR | — | -42.30% |
| 3Y CAGR | — | -27.30% |
| 5Y CAGR | — | -34.80% |
| 10Y CAGR | — | -17.80% |
| Since inception (15.7 years) | -95.5% | -18.00% |
LAB key facts
- Asset type
- Stock
- Asset class
- Equity
- Inception date
- 02/10/2011
- Distribution frequency
- None
- Last close
- $0.63 (as of 2026-10-16)
- Market cap
- $246,932,070
- Average volume
- 647312.0
- Beta
- 1.352
- Payout ratio
- 0.0%
- EPS
- $-0.13
How Dividend Vision calculates yield and returns
Distribution rate (the posted rate) uses calculation basis unavailable. Issuer rates can use a different denominator and date, including ex-date NAV. Trailing-12-month yield is the sum of split-adjusted cash distributions with ex-dates in the last 12 months, divided by the published price. It lags a recent raise or cut. Total return uses split-adjusted close with distributions reinvested on the ex-dividend date (a modeling convention, not the cash-settlement date) from the first stored bar on or after inception through the latest bar, compared with the same window on the benchmark. That is the security's total return, not your personal gain/loss.
Yield and safety methodology · Distribution rate methodology · Distribution Safety Score methodology
Sources and review
Primary sources: prices and distributions from Dividend Vision, derived from vendor EOD data.
Reviewed by Bert Sweet, CEO and Co-owner of Dividend Vision. Methodology: Distribution Safety Score.
LAB risks and drawbacks
Total return has trailed SPY over the available window. The deepest 1-year drawdown on record here is 62.6%.
Who may consider LAB — and who may not
It is a weaker fit for investors who need monthly cash flow (LAB does not currently distribute); investors whose main goal is matching SPY total return. This is educational context, not a recommendation to buy or sell.
More on LAB
Frequently asked questions
Does LAB pay monthly?
No. LAB does not currently distribute.
When does LAB pay a dividend?
LAB does not currently distribute.
How has LAB performed?
Total return is -95.5% over the past 15.7 years, 755.4 points behind SPY at 659.9%. Over the past year its total return — price change plus distributions reinvested — is -51.2%. Its deepest 1-year drawdown was 62.6%.
Tickers
Holdings as-of date unavailable.
| Ticker | Name | Weight |
|---|
See how this investment would fit into your portfolio.